Pune: Serum Institute of India to Develop Vaccine for Monkeypox Amid Global Health Concerns
Pune, 21st August 2024: The rise in monkeypox cases has become a global concern. In response, the Serum Institute of India, based in Pune, has announced plans to develop a vaccine for monkeypox. In Africa, more than 12 nations have reported cases among both children and adults, and the virus is spreading rapidly. Currently, there are limited vaccines available for this disease. The World Health Organization (WHO) has also expressed concern over the situation.
Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India, shared this information in a press release. He stated that the institute is actively working on a vaccine to protect millions of people threatened by monkeypox. Based on current progress, Poonawalla is hopeful that positive results will be achieved within the next year.
